Conference
OPTIMIZING THE USE OF RISK FACTORS TO GUIDE THE COST-EFFECTIVE USE OF PALIVIZUMAB PROPHYLAXIS AGAINST SEVERE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN KOREAN INFANTS BORN 32-35 WEEKS' GESTATIONAL AGE
Authors
Keary I; Kang JM; Paes B; Rodgers-Gray B; Fullarton J; Tarride JE; Yang HJ; Chang YS; Carbonell-Estrany X
Volume
26
Pagination
pp. S125-S125
Publisher
ELSEVIER SCIENCE INC
Publication Date
December 1, 2023
Conference proceedings
VALUE IN HEALTH
Issue
12
ISSN
1098-3015